Why has the Andromeda (ASX:ADN) share price rocketed 26% in a month?

This mining company is having a great run. Here are the details

| More on:
Two cheerful miners shake hands while wearing hi-vis and hard hats celebrating the commencement of a HAstings Technology Metals mine and the impact on its share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Andromeda Metals Ltd (ASX: ADN) share price has been enjoying a stellar run over recent weeks.

Shares in the mining company have soared from 15.5 cents to 19.5 cents in the past four weeks, up 26%. By comparison, the S&P/ASX 200 Index (ASX: XJO) is up around 3% over the past month.

Let's take a look at what may be weighing on the minds of investors.

New mining lease

Andromeda is a South Australian explorer aiming to supply high-quality industrial minerals to the global market. The company's flagship project is the Great White kaolin project on the state's Eyre Peninsula.

Two significant factors weighed on the Andromeda Metals share price in the past month. The first is the pending merger with Minotaur Exploration Ltd (ASX: MEP). If approved, it would provide Andromeda with 100% ownership of the Great White kaolin project.

Andromeda is offering 1.15 new Andromeda shares for each Minotaur share. This offer opened on 8 December and will close on 31 January. Minotaur Directors unanimously recommended shareholders accept the Andromeda offer in a statement released to the market on 8 December. Shares in Andromeda increased 13% between the close on 7 December and 10 December.

The second major event to help the Andromeda share price was the South Australia Minister for Energy and Mining Dan van Holst Pellekaan granting a mining lease and two supporting licences for the Great White kaolin project. Andromeda released a statement to the market on 17 December describing this approval as a "significant positive step forward" for the project. Shares in the company soared nearly 6% between market close on 16 December and 17 December.

Commenting on this approval, managing director James Marsh said:

This really is a fantastic success for all Andromeda stakeholders and a crucial milestone in the evolution of the company. It will allow us to progress with full confidence into a very exciting 2022 and become a sustainable, world-class producer of kaolin minerals.

Once in production a whole range of new and significant halloysite-kaolin opportunities will open up for us, and I would like to thank the whole Andromeda team for their dedication and professionalism.

Andromeda share price snapshot

The Andromeda share price has fallen 34% over the past year but is up more than 5% this week.

For comparison, the S&P/ASX 200 Index (ASX: XJO) has returned nearly 11% to investors in the past year.

This ASX share commands a market capitalisation of around $484 million based on its current share price.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Three small children reach up to hold a toy rocket high above their heads in a green field with a blue sky above them.
Growth Shares

These 4 ASX 200 stocks could jump another 70% to 80% in 2026

These stocks are expected to rocket higher.

Read more »

Two excited woman pointing out a bargain opportunity on a laptop.
Share Gainers

3 ASX 200 stocks jumping higher in this week's falling market

Investors shrugged off the broader market retrace and piled into these three ASX 200 stocks this week.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why EOS, Lotus Resources, REA, and Web Travel shares are dropping today

These shares are ending the week deep in the red. But why?

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Brambles, HMC Capital, ResMed, and Rio Tinto shares are rising today

These shares are avoiding the selloff and are pushing higher on Friday.

Read more »

A woman looks shocked as she drinks a coffee while reading the paper.
Share Fallers

Why is the Web Travel share price crashing 41% on Friday?

ASX investors are pummelling Web Travel shares today. But why?

Read more »

A man looking at his laptop and thinking.
Materials Shares

Rio Tinto shares charge higher after Glencore merger collapses

The parties couldn't come to an agreement.

Read more »

a group of doctors and medical staff in uniform high five in celebration in a hospital setting
Share Market News

Neuren Pharmaceuticals kicks off Phase 3 trial in rare syndrome

Neuren Pharmaceuticals shares are on watch after dosing began in its key Phase 3 trial for Phelan-McDermid syndrome.

Read more »